文献速递颈动脉与弓上血管

年龄影响颈动脉血运重建术的疗效与安全性

Age modifies the efficacy and safety of carotid artery revascularization procedures.
PubMed 文献 · J Vasc Surg · 2019-01-01

基于VQI数据库2005-2017年89,853例患者,评估年龄与CEA和CAS疗效的关系。主要终点为30天及2年卒中及卒中/死亡复合终点。结果显示CAS相对CEA的30天卒中风险在56.5岁时显著,72.5岁时翻倍;CEA疗效随年龄相对稳定,CAS对年龄更敏感。

要点

  • CAS相对CEA的30天卒中风险在56.5岁起显著,72.5岁时翻倍。
  • CEA后卒中风险随年龄增长相对稳定,CAS后风险随年龄递增更明显。
  • CEA随年龄增长的优势持续至术后2年,CAS相对CEA的2年卒中风险在53岁显著,71.5岁翻倍。

核心结论

  • 年龄对颈动脉血运重建的安全性和有效性具有效应修饰作用,CAS的疗效对年龄尤其敏感,而CEA在不同年龄层表现相对稳定。

研究设计与样本

  • 基于Vascular Quality Initiative数据库2005-2017年的多中心注册研究,共纳入89,853例患者,其中26.9%小于65岁,39.1%为65-74岁,34.1%为75岁及以上。

主要发现

  • CAS相对CEA的30天卒中比值比在56.5岁时变得显著,在72.5岁时翻倍。
  • CEA后年龄从76岁增至85岁,卒中风险增加1.3倍(OR 1.30,95%CI 1.05-1.62)。
  • CAS后年龄从65岁增至71岁,卒中OR为1.36(95%CI 1.04-1.76);从71岁增至76岁,OR为1.47(95%CI 1.10-1.96);从76岁增至85岁,OR为1.38(95%CI 1.06-1.81)。
  • CEA随年龄增长的优势持续至术后2年;CAS相对CEA的2年卒中风险在53岁显著,71.5岁翻倍。

临床怎么用

  • 在真实世界人群中,年龄应作为选择CEA或CAS的重要考量因素,尤其对CAS疗效的年龄敏感性需加以关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several randomized clinical trials have shown that carotid artery endarterectomy (CEA) is safer than carotid artery stenting (CAS) in the elderly. However, those studies were limited by their strict inclusion criteria that might make their findings inapplicable to real-world practice. Therefore, the aim of this study was to evaluate the association of age with the efficacy of CEA and CAS in a population-based registry. METHODS: The Vascular Quality Initiative database was inquired (2005-2017). The primary outcome was 30-day and 2-year stroke and a combined outcome of stroke/death. Logistic regression models with age-by-treatment interaction term were fitted adjusting for patients' characteristics. Restricted cubic spline modelling was also implemented. Two-year events were assessed via survival analysis methods. RESULTS: Overall, 89,853 patients were included, 26.9% were less than 65 years of age, 39.1% were 65 to 74 years of age, and 34.1% were 75 years of age or older. The CAS-to-CEA odds of 30-day stroke became significant at age 56.5 and doubled at age 72.5 years. After CEA, the risk of stroke rose by 1.3-fold when age increased from 76 to 85 (odds ratio [OR], 1.30; 95% confidence interval [CI], 1.05-1.62). Yet after CAS, when age increased from 65 to 71 years, the OR of stroke was 1.36 (95% CI, 1.04-1.76); from 71 to 76 years, the OR was 1.47 (95% CI, 1.10-1.96), and from 76 to 85 years the OR was 1.38 (95% CI, 1.06-1.81). The superiority of CEA with increasing age extended to 2 years after the procedure. The CAS-to-CEA 2-year hazard of stroke was significant at age 53 and it doubled at 71.5 years. CONCLUSIONS: In this multicenter registry, we confirmed the effect modification role that age plays in the safety and efficacy of carotid revascularizations. The risk-adjusted effectiveness of CAS was particularly sensitive to patient age, whereas CEA performance was relatively stable across various age strata. Of note, the observed effect was more pronounced and a decade earlier than what previously reported in the ideal setting of a randomized clinical trial.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nejim B, Alshwaily W, Dakour-Aridi H, et al. Age modifies the efficacy and safety of carotid artery revascularization procedures. J Vasc Surg. 2019. PMID: 31010514. doi:10.1016/j.jvs.2018.07.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。